ECSP14024250A - USO INTRAUTERINO DE 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA - Google Patents

USO INTRAUTERINO DE 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA

Info

Publication number
ECSP14024250A
ECSP14024250A ECIEPI201424250A ECPI201424250A ECSP14024250A EC SP14024250 A ECSP14024250 A EC SP14024250A EC IEPI201424250 A ECIEPI201424250 A EC IEPI201424250A EC PI201424250 A ECPI201424250 A EC PI201424250A EC SP14024250 A ECSP14024250 A EC SP14024250A
Authority
EC
Ecuador
Prior art keywords
intrauterine
contraception
well
4in3onas
systems containing
Prior art date
Application number
ECIEPI201424250A
Other languages
English (en)
Inventor
Katja Prelle
Lars Röse
Tuula Valo
Reinhard Nubbemeyer
Harri Jukarainen
Norbert Schmees
Henriikka Korolainen
Original Assignee
Poli Nutri Alimentos S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP14024250(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Nutri Alimentos S A filed Critical Poli Nutri Alimentos S A
Publication of ECSP14024250A publication Critical patent/ECSP14024250A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención describe el uso intrauterino de 18–metil–15ß,16ߖmetilen–19–nor–20–espirox–4–en–3–onas de la fórmula general (1) en la anticoncepción la terapia ginecológica, así como un sistema intrauterino que contiene compuestos de la fórmula 1.
ECIEPI201424250A 2012-04-23 2014-10-24 USO INTRAUTERINO DE 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA ECSP14024250A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23

Publications (1)

Publication Number Publication Date
ECSP14024250A true ECSP14024250A (es) 2015-12-31

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201424250A ECSP14024250A (es) 2012-04-23 2014-10-24 USO INTRAUTERINO DE 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA

Country Status (28)

Country Link
US (1) US20150065472A1 (es)
EP (1) EP2841074A1 (es)
JP (1) JP2015514791A (es)
KR (1) KR20150004807A (es)
CN (1) CN104254333A (es)
AR (1) AR090799A1 (es)
AU (1) AU2013254840A1 (es)
BR (1) BR112014026193A2 (es)
CA (1) CA2871003A1 (es)
CL (1) CL2014002836A1 (es)
CO (1) CO7111255A2 (es)
CR (1) CR20140490A (es)
CU (1) CU20140121A7 (es)
DO (1) DOP2014000241A (es)
EA (1) EA201491922A1 (es)
EC (1) ECSP14024250A (es)
HK (1) HK1205000A1 (es)
IL (1) IL235095A0 (es)
IN (1) IN2014DN07839A (es)
MA (1) MA37444A1 (es)
MX (1) MX2014012849A (es)
PE (1) PE20142438A1 (es)
PH (1) PH12014502372A1 (es)
SG (1) SG11201406582XA (es)
TN (1) TN2014000444A1 (es)
TW (1) TW201350122A (es)
UY (1) UY34758A (es)
WO (1) WO2013160213A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
CN101934078A (zh) * 2000-01-18 2011-01-05 拜耳先灵医药股份有限公司 包含屈螺酮和雌激素的药物组合物及其应用
NZ585546A (en) * 2003-07-16 2011-10-28 Teva Womens Health Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PL403688A1 (pl) * 2010-11-08 2014-02-17 Hll Lifecare Limited Wkladka wewnatrzmaciczna z kontrolowanym uwalnianiem miedzi oraz metoda przygotowywania wkladki copper-T powleczonej cienka warstewka biodegradowalna

Also Published As

Publication number Publication date
CU20140121A7 (es) 2014-12-26
IN2014DN07839A (es) 2015-04-24
CL2014002836A1 (es) 2015-03-13
AR090799A1 (es) 2014-12-10
AU2013254840A1 (en) 2014-11-06
EA201491922A1 (ru) 2015-04-30
IL235095A0 (en) 2014-12-31
CR20140490A (es) 2014-11-17
PE20142438A1 (es) 2015-02-01
MA37444A1 (fr) 2016-11-30
EP2841074A1 (de) 2015-03-04
CN104254333A (zh) 2014-12-31
UY34758A (es) 2013-11-29
KR20150004807A (ko) 2015-01-13
TN2014000444A1 (en) 2016-03-30
CO7111255A2 (es) 2014-11-10
US20150065472A1 (en) 2015-03-05
MX2014012849A (es) 2015-02-05
PH12014502372A1 (en) 2015-01-26
TW201350122A (zh) 2013-12-16
BR112014026193A2 (pt) 2017-06-27
WO2013160213A1 (de) 2013-10-31
DOP2014000241A (es) 2014-12-31
CA2871003A1 (en) 2013-10-31
SG11201406582XA (en) 2014-11-27
HK1205000A1 (en) 2015-12-11
JP2015514791A (ja) 2015-05-21

Similar Documents

Publication Publication Date Title
CR20150629A (es) Compuestos químicos
CO7111287A2 (es) Composiciones plaguicidas y procesos relacionados
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
GT201400241A (es) "uso de pro-fungicidas de uk-2a para el control de la sigatoka negra"
ECSP11011390A (es) Compuestos espiro-amidas sustituidas
CR20210079A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
CO6640285A2 (es) 5-alquinil-pirimidinas
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
ECSP13012519A (es) Compuestos sustituidos de benzamida
UY35129A (es) Compuestos heteroaromáticos y su uso como ligandos d1 de dopamina
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
BR112015030308A2 (pt) antagonistas de progesterona de imidazolila
CL2016001210A1 (es) Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
ECSP14024250A (es) USO INTRAUTERINO DE 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ߖMETILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional
CL2015003736A1 (es) Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol
BR102014007923A8 (pt) sistema nanoestruturado polimérico e seu uso
CR20140489A (es) Uso de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas en el tratamiento de menorragia, y sistemas intrauterinos que comprenden 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas para el tratamiento de t
UA89388U (ru) Применение глюкозамина гидрохлорида как средства, защищающего организм от системного воздействия высоких температур
CU24344B1 (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas
ECSP12012115A (es) 5-alquinil-pirimidinas
UY33816A (es) ?nuevas triazolilfenil sulfonamidas como inhibidores de serina/treonina cinasa?.
CR11704S (es) Dispositivo de liberación de química de un contenedor de química